Felix Hammann
Felix Hammann
University Hospital Bern
Patvirtintas el. paštas
Ivermectin and COVID-19: keeping rigor in times of urgency
C Chaccour, F Hammann, S Ramón-García, NR Rabinovich
The American journal of tropical medicine and hygiene 102 (6), 1156, 2020
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled …
C Chaccour, A Casellas, A Blanco-Di Matteo, I Pineda, ...
EClinicalMedicine 32, 100720, 2021
Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects
PC Dolder, Y Schmid, AE Steuer, T Kraemer, KM Rentsch, F Hammann, ...
Clinical pharmacokinetics 56, 1219-1230, 2017
Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
C Chaccour, F Hammann, NR Rabinovich
Malaria Journal 16 (1), 1-16, 2017
Green tea extract enhances parieto-frontal connectivity during working memory processing
A Schmidt, F Hammann, B Wölnerhanssen, AC Meyer-Gerspach, J Drewe, ...
Psychopharmacology 231 (19), 3879-3888, 2014
Prediction of adverse drug reactions using decision tree modeling
F Hammann, H Gutmann, N Vogt, C Helma, J Drewe
Clinical Pharmacology & Therapeutics 88 (1), 52-59, 2010
Computational prediction of blood-brain barrier permeability using decision tree induction
C Suenderhauf, F Hammann, J Huwyler
Molecules 17 (9), 10429-10445, 2012
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone
O Kummer, F Hammann, C Moser, O Schaller, J Drewe, S Krähenbühl
European journal of clinical pharmacology 67, 63-71, 2011
Classification of Cytochrome P450 Activities Using Machine Learning Methods
F Hammann, H Gutmann, U Baumann, C Helma, J Drewe
Molecular pharmaceutics 6 (6), 1920-1926, 2009
Neural effects of green tea extract on dorsolateral prefrontal cortex
S Borgwardt, F Hammann, K Scheffler, M Kreuter, J Drewe, C Beglinger
European journal of clinical nutrition 66 (11), 1187-1192, 2012
Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls
H Gutmann, P Hruz, C Zimmermann, A Straumann, L Terracciano, ...
Digestion 78 (2-3), 154-162, 1952
Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital
V Schöning, E Liakoni, C Baumgartner, AK Exadaktylos, WE Hautz, ...
Journal of translational medicine 19, 1-11, 2021
Screening for an ivermectin slow-release formulation suitable for malaria vector control
C Chaccour, ÁI Barrio, AGG Royo, DM Urbistondo, H Slater, F Hammann, ...
Malaria Journal 14 (1), 1-9, 2015
An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography–tandem mass spectrometry
S Sturm, F Hammann, J Drewe, HH Maurer, A Scholer
Journal of Chromatography B 878 (28), 2726-2732, 2010
Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects
PC Dolder, P Strajhar, P Vizeli, F Hammann, A Odermatt, ME Liechti
Frontiers in pharmacology 8, 617, 2017
Comparison of the dissolution and pharmacokinetic profiles of two galenical formulations of the endothelin receptor antagonist macitentan
O Kummer, M Haschke, F Hammann, M Bodmer, S Bruderer, Y Regnault, ...
European journal of pharmaceutical sciences 38 (4), 384-388, 2009
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
C Chaccour, G Abizanda, Á Irigoyen-Barrio, A Casellas, A Aldaz, ...
Scientific reports 10 (1), 1-11, 2020
Combinatorial QSAR modeling of human intestinal absorption
C Suenderhauf, F Hammann, A Maunz, C Helma, J Huwyler
Molecular pharmaceutics 8 (1), 213-224, 2011
Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers
U Duthaler, C Suenderhauf, MO Karlsson, J Hussner, ...
British journal of clinical pharmacology 85 (3), 626-633, 2019
Prediction of clinically relevant drug‐induced liver injury from structure using machine learning
F Hammann, V Schöning, J Drewe
Journal of Applied Toxicology 39 (3), 412-419, 2019
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20